VeriMomcyclohydroxyprolyl serine hamilelikte güvenli mi?
No harmonised CLP reproductive classification (no entry in ECHA Annex VI), no SCCS or CIR safety assessment identified, and no peer‑reviewed reproductive or developmental toxicity data were found for cyclo(L‑Hyp‑L‑Ser) / JBP485 (CAS 211868‑63‑2). Published studies describe pharmacology/wound‑healing and oral absorption via peptide transporters, not reproductive toxicity, supporting default no‑hazard. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/31393124/?utm_source=openai))
Related ingredients
Frequently asked questions
- cyclohydroxyprolyl serine hamilelikte güvenli mi?
- No harmonised CLP reproductive classification (no entry in ECHA Annex VI), no SCCS or CIR safety assessment identified, and no peer‑reviewed reproductive or developmental toxicity data were found for cyclo(L‑Hyp‑L‑Ser) / JBP485 (CAS 211868‑63‑2). Published studies describe pharmacology/wound‑healing and oral absorption via peptide transporters, not reproductive toxicity, supporting default no‑hazard. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/31393124/?utm_source=openai))
- cyclohydroxyprolyl serine emzirirken güvenli mi?
- No data on transfer into human milk or lactation effects were identified. There is no regulatory reproductive/lactation classification or CIR/SCCS opinion; available literature describes biological activity (wound healing, transporter substrates) but not lactation or pup exposure. Default: no evidence of hazard. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/19505367/?utm_source=openai))
- cyclohydroxyprolyl serine bebek cildi için güvenli mi?
- No infant‑specific toxicology or dermal developmental studies were located. Dermal exposure from cosmetics is expected to give negligible absorption in adults; however, cyclo(L‑Hyp‑L‑Ser) is a small cyclic dipeptide with published evidence of intestinal uptake via peptide transporters (i.e., it can be absorbed systemically after non‑dermal administration), so per the scoring rules baby exposure is increased by +1 relative to adult (adult e=0 → baby e=1). No infant‑specific hazard or mechanism evidence found. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/31393124/?utm_source=openai))
- VeriMom cyclohydroxyprolyl serine nasıl puanlıyor?
- VeriMom cyclohydroxyprolyl serine'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte cyclohydroxyprolyl serine yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.